4//SEC Filing
Berenson Stephen 4
Accession 0001127602-22-012859
CIK 0001682852other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:47 PM ET
Size
11.2 KB
Accession
0001127602-22-012859
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Berenson Stephen
Director
Transactions
- Exercise/Conversion
Common Stock
2022-04-28+703→ 20,801 total - Award
Restricted Stock Units
2022-04-28+670→ 670 totalExercise: $0.00→ Common Stock (670 underlying) - Award
Stock Option (Right to Buy)
2022-04-28+4,061→ 4,061 totalExercise: $142.52→ Common Stock (4,061 underlying) - Exercise/Conversion
Restricted Stock Units
2022-04-28−703→ 0 totalExercise: $0.00→ Common Stock (703 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The shares subject to this restricted stock unit award vested in full on April 28, 2022.
- [F3]This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
- [F4]The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001760671
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 4:47 PM ET
- Size
- 11.2 KB